应答指导治疗策略(RGT)优化EBTB治疗的临床研究(5)
[18] Perazzo H，Jorge MJ，Silva JC，et al. Micro-costing analysis of guideline-based treatment by direct-acting agents：The real-life case of hepatitis C management in Brazil[J]. Bmc Gastroenterology，2017，17(1)：119.
[19] Berg T，Petersen J. Predicting long-term response after stopping nucleos(t)ide analogue treatment in HBeAg-negative chronic hepatitis B[J]. Journal of Hepatology，2018，68(5)：S0168827818300643.
[20] Harris Jennifer B，Ward Melea A，Schwab Phil. Is response-guided therapy being applied in the clinical setting？ The hepatitis C example[J]. American Health & Drug Benefits，2015，8(1)：22-35.
[21] Mantry Parvez S，Wu Chunxia，Weinstein Jeffrey S，et al. Mo1848 results of response guided therapy(Rgt) using telaprevir basedtriple therapy in liver transplant recipients with recurrence of hepatitis C virus(HCV) infection[J].Gastroenterology，2013，144(5)：S-1028-S-1028.
[22] 沙巍，何婭，蒋瑞华，等. 实时荧光核酸恒温放大检测(SAT)法对肺结核诊断价值的研究[J]. 中国防痨杂志，2012，34(6)：377-379.
(收稿日期：2019-06-19), 百拇医药(李月翠 李成行 周晶 胡伟跃 骆红霞 臧颖惠 张莉莉 倪晓莉)
[19] Berg T，Petersen J. Predicting long-term response after stopping nucleos(t)ide analogue treatment in HBeAg-negative chronic hepatitis B[J]. Journal of Hepatology，2018，68(5)：S0168827818300643.
[20] Harris Jennifer B，Ward Melea A，Schwab Phil. Is response-guided therapy being applied in the clinical setting？ The hepatitis C example[J]. American Health & Drug Benefits，2015，8(1)：22-35.
[21] Mantry Parvez S，Wu Chunxia，Weinstein Jeffrey S，et al. Mo1848 results of response guided therapy(Rgt) using telaprevir basedtriple therapy in liver transplant recipients with recurrence of hepatitis C virus(HCV) infection[J].Gastroenterology，2013，144(5)：S-1028-S-1028.
[22] 沙巍，何婭，蒋瑞华，等. 实时荧光核酸恒温放大检测(SAT)法对肺结核诊断价值的研究[J]. 中国防痨杂志，2012，34(6)：377-379.
(收稿日期：2019-06-19), 百拇医药(李月翠 李成行 周晶 胡伟跃 骆红霞 臧颖惠 张莉莉 倪晓莉)